MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding,…
29,200€
5,04%
Echtzeit-Aktienkurs Morphic Holding Inc.
Bid:
Ask:
Nachrichten zur Morphic Holding Inc. Aktie
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)
NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (https://aftlaw.com/), a nationally recognized law…
MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
SAN DIEGO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding,…
MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding,…
MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding,…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Morphic Under Investigation: Shareholders Are Encouraged to Contact Johnson Fistel for Their Options
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating…
MORF INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
SAN DIEGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
MORF INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
SAN DIEGO, Oct. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…
Investigation of Morphic Holding, Inc. (MORF) Announced by Holzer & Holzer, LLC
ATLANTA, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Morphic Holding, Inc. (“Morphic”…
Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference
WALTHAM, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 205.187$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-08-01...…
Morphic Holding, Inc. (MORF) Reports Q2 Loss, Lags Revenue Estimates
Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -2.22% and 100%, respectively, for the quarter ended June 2023.…
Form 8-K Morphic Holding, Inc. For: Aug 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q Morphic Holding, Inc. For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 205.178$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-07-03...…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 52.929$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-06-12...…
Insiderhandel: General Counsel and Secretary verkauft Aktien von Morphic Holding im Wert von 465.742$
Devaul, William - Vorstand - Tag der Transaktion: 2023-06-07...…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 205.519$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-06-01...…
Form 8-K Morphic Holding, Inc. For: Jun 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: General Counsel and Secretary verkauft Aktien von Morphic Holding im Wert von 228.236$
Devaul, William - Vorstand - Tag der Transaktion: 2023-05-23...…
Insiderhandel: SVP Finance and CAO verkauft Aktien von Morphic Holding im Wert von 600.000$
Farrell, Robert E Jr - Vorstand - Tag der Transaktion: 2023-05-23...…
Insiderhandel: General Counsel and Secretary verkauft Aktien von Morphic Holding im Wert von 6.000$
Devaul, William - Vorstand - Tag der Transaktion: 2023-05-24...…
Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 183.857$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-05-03...…
Insiderhandel: Aufsichtsrat kauft Aktien von Morphic Holding im Wert von 47.250.000$
Springer, Timothy A. - Aufsichtsrat - Tag der Transaktion: 2023-05-03...…
Form 8-K Morphic Holding, Inc. For: May 02
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Morphic Therapeutic slumps 6%, prices $240M offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering
WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a…
Insiderhandel: President and CEO verkauft Aktien von Morphic Holding im Wert von 1.344.667$
Tipirneni, Praveen P. - Vorstand - Tag der Transaktion: 2023-04-25...…
Insiderhandel: SVP Finance and CAO verkauft Aktien von Morphic Holding im Wert von 547.100$
Farrell, Robert E Jr - Vorstand - Tag der Transaktion: 2023-04-25...…
Insiderhandel: President verkauft Aktien von Morphic Holding im Wert von 1.602.129$
Rogers, Bruce - Vorstand - Tag der Transaktion: 2023-04-25...…
Insiderhandel: CFO and COO verkauft Aktien von Morphic Holding im Wert von 2.735.500$
Schegerin, Marc - Vorstand - Tag der Transaktion: 2023-04-25...…
The Zacks Analyst Blog Highlights Biogen, Incyte, Morphic Therapeutic and bluebird bio
Biogen, Incyte, Morphic Therapeutic and bluebird bio are included in this Analyst Blog....…
Morphic Holding down 10% despite bottom line earnings beat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue Estimates
Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -5.88% and 78.59%, respectively, for the quarter ended March 2023.…
Form 8-K Morphic Holding, Inc. For: Apr 25
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023
Call to discuss topline data from EMERALD-1 Phase 2a study of MORF-057 in adults with moderate to severe ulcerative colitis…
Insiderhandel: SVP Finance and CAO verkauft Aktien von Morphic Holding im Wert von 450.000$
Farrell, Robert E Jr - Vorstand - Tag der Transaktion: 2023-04-20...…
Insiderhandel: President verkauft Aktien von Morphic Holding im Wert von 403.463$
Rogers, Bruce - Vorstand - Tag der Transaktion: 2023-04-17...…
Insiderhandel: SVP Finance and CAO verkauft Aktien von Morphic Holding im Wert von 825.001$
Farrell, Robert E Jr - Vorstand - Tag der Transaktion: 2023-04-17...…
Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last?
Morphic Holding, Inc. (MORF) saw its shares surge in the last session with trading volume being higher than average. The…
Insiderhandel: CFO and COO verkauft Aktien von Morphic Holding im Wert von 2.250.050$
Schegerin, Marc - Vorstand - Tag der Transaktion: 2023-03-07...…
Morphic to Present at TD Cowen 43rd Annual Health Care Conference
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation…